• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Journal of Pharmacology and Toxicology
  2. Vol 1 (2), 2006
  3. 126-133
  • Issues
    Online First Current Issue All Issues
  • Information About
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Journal of Pharmacology and Toxicology

Year: 2006 | Volume: 1 | Issue: 2 | Page No.: 126-133
DOI: 10.3923/jpt.2006.126.133

Facebook Twitter Reddit Linkedin E-mail
Google Scholar ASCI
Research Article

Synthesis and Biological Evaluation of 1-(2’, 4’-dimethoxyphenacyl)-4-acetyl-4-phenylpiperidinium bromide in Intestinal and Cardiovascular Tissues

Syed I.H. Taqvi
Federal Urdu University of Arts, Science and Technology, University Road, Karachi, Pakistan

Mohammad T. Aftab
Post Graduate Medical Institute, Baqai Medical University, Karachi, Pakistan

Muhammad N. Ghayur
Department of Biomedical and Biological Sciences, The Aga Khan University, Stadium Road, Karachi-74800, Pakistan

Anwar H. Gilani
Department of Biomedical and Biological Sciences, The Aga Khan University, Stadium Road, Karachi-74800, Pakistan

Zafar S. Saify
Faculty of Pharmacy, University of Karachi, Karachi, Pakistan

1-(2’, 4’-dimethoxyphenacyl)- 4-acetyl-4-phenylpiperidinium bromide is a synthetic piperidine compound which was screened in isolated intestinal and aortic smooth muscle and Langendorff’s heart preparations. The test compound exhibited dose-dependent spasmolytic effect on the spontaneous and high K+ (75 mM) contracted isolated rabbit jejunum with respective EC50 values of 0.08 mM (0.05-0.13, 95% CI) and 0.12 mM (0.06-0.21). The Ca++ channel blocking (CCB) activity was confirmed when the test compound (0.05-0.1 mM) shifted the Ca++ dose-response curves to the right, similar to that produced by verapamil (0.3-1.0 μM), a standard CCB. In the isolated rabbit aorta, the test compound showed a dose-dependent vasodilator effect on high K+ (75 mM)-induced contractions with an EC50 value of 0.04 mM (0.02-0.08) while also suppressed the norepinephrine (1 μM) peak responses with an EC50 value of 0.04 mM (0.03-0.06). When tested in Langendorff perfused rabbit heart preparation, it exhibited a negative inotropic effect in the ventricles with EC50 value of 0.59 mM (0.04-8.86) with negligible effect on the rate of ventricular contractions. The results show inhibitory effects of the test compound on intestinal and vascular smooth muscle preparations and a cardio-suppressant effect, possibly mediated via blockade of voltage and receptor-operated Ca++ channels.
PDF Fulltext XML References

How to cite this article

Syed I.H. Taqvi, Mohammad T. Aftab, Muhammad N. Ghayur, Anwar H. Gilani and Zafar S. Saify, 2006. Synthesis and Biological Evaluation of 1-(2’, 4’-dimethoxyphenacyl)-4-acetyl-4-phenylpiperidinium bromide in Intestinal and Cardiovascular Tissues. Journal of Pharmacology and Toxicology, 1: 126-133.

DOI: 10.3923/jpt.2006.126.133

URL: https://scialert.net/abstract/?doi=jpt.2006.126.133

Leave a Comment


Your email address will not be published. Required fields are marked *

Article Trend



Total views 1966

References


  1. Bolton, T.B., 1979. Mechanism of action of transmitters and other substances on smooth muscles. Physiol. Rev., 59: 606-618.

  2. Clark, R.D., J.M. Caroon, A.F. Kluge, D.B. Repke and A.P. Roszkowski et al., 1983. Synthesis and antihypertensive activity of 4'-substituted spiro (4H-3, 1-benzoxazine-4, 4'-piperidin)-2(1H)-ones. J. Med. Chem., 26: 657-661.
    PubMed

  3. Conti, C.R., C.J. Pepine, R.L. Feldman and J.A. Hill, 1985. Calcium antagonists. Cardiology, 72: 297-321.

  4. Farre, A.J., M. Colombo, M. Fort and B. Gutierrez, 1991. Differential effects of various Ca2+ antagonists. Gen. Pharmacol., 22: 177-181.
    PubMed

  5. Anwar-ul, S., H. Gilani and L. B. Cobbin, 1986. The cardio-selectivity of himbacine: A muscarine receptor antagonist. Naunyn-Schmiedebergs Arch. Pharmacol., 332: 16-20.
    CrossRefPubMedDirect Link

  6. Godfraind, T., R. Miller and M. Wibo, 1986. Calcium antagonism and calcium entry blockade. Pharmacol. Rev., 38: 321-416.
    Direct Link

  7. Godfraind, T., 1987. Classification of calcium antagonists. Am. J. Cardiol., 59: 11-23.
    PubMedDirect Link

  8. Karaki, H., 2004. Historical techniques: Cytosolic Ca++ and contraction in smooth muscle. Trends Pharmacol. Sci., 25: 388-393.

  9. Maillard, J., M. Langlois, P. Delaunary, T. VoVan and J. Chenu et al., 1972. Cycloalkane spiroheterocyclic compounds. J. Med. Chem., 15: 1123-1128.

  10. Malecot, H. and W. Trautwein, 1987. On the relationship between Vmax of slow responses and Ca++-current availability in whole-cell clamped guinea-pig heart cell. Pflugers Arch., 410: 15-22.
    PubMedDirect Link

  11. North, R.A., 1986. Opioid receptor types and membrane ion channels. Trends Neurosci., 11: 114-117.

  12. NRC, 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC., USA., ISBN-10: 0309053773, Pages: 140.
    Direct Link

  13. Saeed, M., Z.S. Saify, Z. Iqbal and N. Islam, 1997. Synthesis of 4-hydroxypiperidine derivatives and their screening for analgesic activity. Arch. Pharm. Res., 20: 338-341.

  14. Saeed, M., Z.S. Saify, A.H. Gilani and Z. Iqbal, 1998. Studies on the effects of piperidine derivatives on blood pressure and smooth muscles contractions. Arch. Pharm. Res., 21: 370-373.
    CrossRefPubMedDirect Link

  15. Saify, Z.S., N. Mushtaq, K.M. Khan, S. Perveen and S.T. Shah et al., 2005. Synthesis and pharmacological activity of 4-(4'-(chlorophenyl)-4-hydroxypiperidine) derivatives. Chem. Pharm. Bull., 53: 64-66.

  16. Staff Department of Pharmacology, University of Edinburgh, 1970. Pharmacological Experiments on Isolated Preparations. E and S Livingstone, Edinburgh, pp: 116-119.

  17. Takai, H., H. Obase, M. Teranishi, A. Karasawa and K. Kubo et al., 1985. P. I. Synthesis of 1'-substituted spiro(4H-3,1-benzoxazine-4,4'-piperidin)-2(1H)-one derivatives and evaluation of their antihypertensive activity. Chem. Pharm. Bull., 33: 1129-1139.

  18. Triggle, D.J., 1992. Textbook of Pharmacology. W.B. Saunders Co., Philadelphia, pp: 453-479.

Keywords


  • Piperidine analogue
  • spasmolytic
  • Ca++ antagonist
  • vasodilator
  • specific inotropic

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved